ANALYSIS: Ten rare earth stocks listed on the ASX gained an average of 168% in the last six months in the lead up to the US-Australian deal signed in October.
Shoeshine talks to an investor group that lost millions.
Legalising cannabis will put the onus on employers to prove how much weed is too much.
The NZX-listed company is up for its sixth reinvention since being founded in 1983.
The hi-tech firm stands on the brink of a 5G boom, but investors have heard it all before.
The fast food chain has to take a risk if it wants to hit its $1b revenue target.
The former peer-to-peer lender may soon be offering mums and dads another way in.
The company has to assess a regulatory price reset and duty-free bid by 2022.
Let’s hope Covid-hit SMEs can access the government assistance this time around.
Are schemes of arrangement still fit for purpose?